Our Leadership Team
Driving Innovation in Radiation Therapy QA
Meet the leadership team at ScandiDos – experts driving innovation in radiation therapy QA with a focus on precision, efficiency, and patient safety.

Anders Murman
Interim CEO
Anders Murman has served as Interim CEO since May 2026. He holds a Master of Science in Engineering Physics from Uppsala University and has extensive experience from the medical device industry. Anders spent the first 21 years of his career in radiation therapy at Helax, Nucletron, and RaySearch, where he held roles including Service Manager and Development Manager. He later served as CTO at Aerocrine and Pharmacolog, before becoming co-founder and CEO of Deversify, focusing on financing and global commercialization in consumer markets. Anders joined ScandiDos in 2025.

Henriette Münch
CFO
Henriette Münch has served as the Chief Financial Officer since 2021 and has an extensive background in global finance within the medical device industry. Prior to joining ScandiDos, Henriette held the role of Finance, Administration & Personnel Manager for northern Europe at D-link. Before D-Link, Henriette was CFO at Maquet Nordic (Getinge Group).

Mikael Palm
VP Global Service and Product Management
Mikael has worked in the radiotherapy field for over 20 years, primarily in service and support but also in development. His previous experience includes companies like Oncolog Medical, MDS Nordion, and Precitron. He joined ScandiDos in 2008.

Daniel Pederson
CTO and Head of QA&RA
Daniel Pederson has served as the QA/RA Manager at ScandiDos since 2020. He has more than 14 years of experience working in medical technology companies. Over the past 10 years, Daniel has primarily worked as quality manager and regulatory manager for small and medium-sized medical technology companies. He has also lectured and carried out training together with Swedish Medtech regarding the development, improvement, implementation, and maintenance of quality management systems.